StockData
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31

Can B Corp

Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)

Close on Oct 19, 2026

Market cap
$981.54K
P/E (TTM)
–
Dividend yield
–

Can B Corp revenue by segment

By business segment

By product or service

RevenueFY2023FY2022FY2021FY2020FY2019FY2018FY2017% of revenueYoY
Product [Member]$1.34M$5.52M––$2.30M$651.98K$79.03K62.0%-75.8%
Service [Member]$819.63K$1.16M––$1.20K$16.63K$43.72K38.0%-29.4%
Product Sales [Member]–$5.52M$4.16M$1.71M$2.30M––––
Service Revenue [Member]–$1.16M$447.55K$1.25K$1.20K––––

By region

From the segment and revenue-disaggregation notes of Can B's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.